Acceptance of the 2016 Eminent Parasitologist Award: Chemotherapy in the Context of Emerging Parasitic Diseases.
It seems inevitable that chemotherapy will continue, at least in the near-term, to be a significant factor in the control of infectious diseases. The effectiveness of new drugs has invariably been reduced by the emergence of drug resistance. Efforts to thwart resistance should continue, but there are also other areas that might profitably be re-examined. They include (1) methods of new-drug discovery; (2) selection of parasite life-cycle targets; (3) epidemiological determinants of effectiveness in large-scale control programs; and (4) the economic, managerial, psychological, and political ramifications of drug discovery and drug utilization.
Research Institute for Scientists Emeriti, Drew University, Madison, New Jersey 07940.
William C
WC
Campbell
D000818:Animals; D001363:Awards and Prizes; D021821:Communicable Diseases, Emerging / Q000188:drug therapy* / Q000469:parasitology*; D055808:Drug Discovery / Q000379:methods*; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000379:methods*; D006801:Humans; D010272:Parasitic Diseases / Q000188:drug therapy*; D010274:Parasitology; D012958:Societies, Scientific; D014481:United States